Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Protein Engineering. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112813131A reveals a high-efficiency carboxylesterase for producing Edoxaban intermediates with superior substrate tolerance and optical purity.
Patent CN113481181B details a novel esterase mutant for resolving indoline derivatives, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN110382705B details a novel enzymatic route for L-Alanyl-L-Glutamine using engineered acyltransferase, offering high purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN112899246B details novel KmAKR mutants for synthesizing chiral statin side chains with superior stability and stereoselectivity for API manufacturing.
Patent CN115109769B reveals L-threonine aldolase mutants enabling >99% conversion for L-serine synthesis. Discover cost-effective biocatalytic solutions for pharmaceutical intermediates.
Patent CN110004119B discloses a thermostable epsilon-ketoester reductase mutant enabling efficient synthesis of (R)-alpha-lipoic acid precursors with reduced catalyst loading and enhanced stability.
Patent CN115851863B reveals enzymatic route for spongane skeletons. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing.
Patent CN113337494B reveals high-purity enzymatic synthesis reducing waste and cost for reliable pharmaceutical intermediates supply chains globally.
Patent CN111094557B details novel ADH mutants enabling cost-effective, high-ee biocatalytic synthesis of chiral biaryl alcohols for antihistamine drugs.
Patent CN115948356B reveals high-efficiency carbonyl reductase mutants for lipoic acid intermediates, offering supply chain stability and cost reduction.
Patent CN113817693A reveals a breakthrough PpYSDR mutant for testosterone synthesis, offering superior yield and greener manufacturing for reliable pharmaceutical intermediate suppliers.
Patent CN121495896A reveals enhanced enzyme catalysis for chiral amine synthesis offering significant cost reduction and supply chain reliability for agrochemical manufacturing.
Patent CN115109769A reveals T202S/T202G mutants enabling >99% conversion at high formaldehyde concentrations for efficient L-serine production.
Patent CN112280755B reveals mutant enzyme technology for GHK tripeptide. Achieve high yield and purity with scalable enzymatic processes for cosmetic and pharma applications.